Please login to the form below
immunisation
This page shows the latest immunisation news and features for those working in and with pharma, biotech and healthcare.
WHO launches funding appeal for greater Horn of Africa prompted by food crisis
Services like therapeutic feeding programmes, primary health care, immunisation, safe deliveries and mother and child services can be the difference between life and death for those caught up in these awful
Latest news
-
EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
In February 2022, the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for MVA-BN RSV, for active immunisation for prevention of LRTD caused by RSV in adults aged
-
Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
The Pfizer/BioNTech COVID-19 vaccine, which is based on BioNTech’s proprietary mRNA technology, is authorised by the FDA under EUA for active immunisation in individuals aged six months and
-
Sanofi and GSK share positive data for two COVID-19 booster vaccine trials
In the phase 3 VAT02 cohort 2 trial, the Sanofi/GSK vaccine candidate caused – at day 15 post-immunisation – a significant boost in antibody titres above baseline against multiple variants of
-
FDA approves GSK’s Priorix vaccine for measles, mumps and rubella
Temi Folaranmi, vice president and vaccines therapeutic area head of US Medical Affairs at GSK said: “Outbreaks of measles in recent years demonstrate how quickly diseases can return without widespread immunisation. ... has facilitated the immunisation
-
EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
The vaccine is intended for active immunisation of vulnerable populations to prevent carriage and symptomatic infection with COVID-19 during the pandemic.
More from news
Approximately 2 fully matching, plus 167 partially matching documents found.
Latest Intelligence
-
Trust in the new vaccines – the vital role of healthcare communications
Vaccine hesitancy, of course, existed long before COVID-19, but resistance to the routine immunisation of children has largely been associated with the ‘anti-vax’ movement.
-
Now that COVID-19 vaccines have been approved, it’s our turn, healthcare communicators
5. Reconsider your choices. The WHO summed it up by stating that ‘immunisation [in general] is a global health and development success story, saving millions of lives every year’.
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Enforcement of restrictions on movement and postponement of some immunisation programmes have, in some areas, taken this choice out of their hands. ... BCG, widely used for childhood immunisation against tuberculosis, has been particularly affected due
-
Risks, reforms and rewards: the evolving Russian healthcare market
The period also saw male life expectancy fall, various diseases re-emerge and the suspension of immunisation programmes in various parts of the country.
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
And more importantly, to develop and implement evidence-based strategies that rebuild trust and increase immunisation rates. ... benefits and risks of immunisation and view it as both their right and responsibility.
More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest appointments
-
New faces at 90TEN, Lucid Group and Porterhouse
In that role, Cook delivered initiatives to improve national health, including promoting responsible antibiotic use, protecting against STIs and encouraging rates of childhood immunisation.
-
Burson-Marsteller hires senior DH press officer
In her previous role, Moore worked with both public health ministers and the chief medical officer, developing proactive and reactive communications strategies for issues including immunisation, genetics, obesity and alcohol.
-
Kane & Finkel announces new European director
In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Data-driven healthcare communications
Accessed October 2021]. Public Health England (PHE) National flu immunisation programme 2019/20.
-
The UK has approved the first vaccine for COVID-19. What now?
by Glen Halliwell, Business Unit Director, Langland. The Joint Committee on Vaccination and Immunisation has quickly answered the first question regarding the priority vaccination groups for phase one. ... hesitation. The challenge of rolling out a brand
-
Is the world ready for a COVID-19 vaccine?
the help of local organisations, manage the roll out of routine immunisations every day. ... challenges for countries and states that do not have immunisation registries or ways of tracking patients.
-
Dice Medical Communications
Mind the Gap – Challenging Immunisation Apathy and Misinformation.
-
UK vs US: what makes a successful immunisation programme?
Before discussing these, let’s have a look at how immunisation uptake differs between the two countries. ... In the US this is The American Committee on Immunization Practices (ACIP) and in the UK it is the Joint Committee for Vaccination and
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Janssen announces positive results supporting Rybrevant and lazertinib combination treatment for NSCLC
- Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
- NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
- Sanofi and Innovent Biologics to develop oncology drugs for patients in China
- WHO launches funding appeal for greater Horn of Africa prompted by food crisis
PMHub
Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...
Latest intelligence
- Animation: Living With
- The journey from the patient's perspective...
- Achieving communication excellence by targeting the right channel at the right time
- By Danny Buckland...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
